{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T05:27:25Z","timestamp":1738474045395,"version":"3.35.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ijcard.2024.132866","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T16:51:37Z","timestamp":1733158297000},"page":"132866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of care specialty with anticoagulant prescription and clinical outcomes in newly diagnosed atrial fibrillation: Results from the GARFIELD-AF registry"],"prefix":"10.1016","volume":"421","author":[{"given":"C. Fielder","family":"Camm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saverio","family":"Virdone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Jerjes-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seil","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Oto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A.A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. John","family":"Camm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen S.","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"Ragy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay K.","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2024.132866_bb0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2024.132866_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/03007995.2021.1982684","article-title":"The burden of undertreatment and non-treatment among patients with non-valvular atrial fibrillation and elevated stroke risk: a systematic review","volume":"38","author":"Sussman","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ijcard.2024.132866_bb0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1378\/chest.10-2436","article-title":"Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project","volume":"140","author":"Gorin","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2024.132866_bb0020","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/joa3.12588","article-title":"Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world","volume":"37","author":"Kozie\u0142","year":"2021","journal-title":"J. Arrhythm."},{"key":"10.1016\/j.ijcard.2024.132866_bb0025","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2018.07.077","article-title":"Provider specialty, anticoagulation, and stroke risk in patients with atrial fibrillation and cancer","volume":"72","author":"O\u2019Neal","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132866_bb0030","article-title":"Provider specialty, anticoagulation prescription patterns, and stroke risk in atrial fibrillation","volume":"7","author":"O\u2019Neal","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2024.132866_bb0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jacc.2017.04.054","article-title":"Treating specialty and outcomes in newly diagnosed atrial fibrillation: from the TREAT-AF study","volume":"70","author":"Perino","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132866_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-015-0371-8","article-title":"Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany\u2013results from the German AFNET registry","volume":"15","author":"Haeusler","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ijcard.2024.132866_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ahj.2012.10.010","article-title":"Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study","volume":"165","author":"Turakhia","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2024.132866_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000110","article-title":"Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry","volume":"2","author":"Fosbol","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2024.132866_bb0055","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.cjca.2017.10.003","article-title":"The relationship between cardiologist care and clinical outcomes in patients with new-onset atrial fibrillation","volume":"33","author":"Singh","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132866_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2011.09.011","article-title":"International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)","volume":"163","author":"Kakkar","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2024.132866_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002506","article-title":"Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke","volume":"10","author":"Siegal","year":"2023","journal-title":"Open. Heart."},{"key":"10.1016\/j.ijcard.2024.132866_bb0070","first-page":"114","article-title":"Evolving quality standards for large-scale registries: the GARFIELD-AF experience","volume":"3","author":"Fox","year":"2017","journal-title":"Eur. Heart. J. Qual. Care. Clin. Outcomes."},{"key":"10.1016\/j.ijcard.2024.132866_bb0075","doi-asserted-by":"crossref","first-page":"oead051","DOI":"10.1093\/ehjopen\/oead051","article-title":"Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF, euro","volume":"3","author":"Camm","year":"2023","journal-title":"Heart. J. Open."},{"issue":"2020","key":"10.1016\/j.ijcard.2024.132866_bb0080","first-page":"373","article-title":"ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2020","journal-title":"Euro. Heart. J."},{"key":"10.1016\/j.ijcard.2024.132866_bb0085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/ehjqcco\/qcab028","article-title":"GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation","volume":"8","author":"Fox","year":"2022","journal-title":"Eur. Heart. J. Qual. Care. Clin. Outcomes."},{"key":"10.1016\/j.ijcard.2024.132866_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2024.132866_bb0095","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2024.132866_bb0100","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2024.132866_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/insr.12214","article-title":"A tutorial on multilevel survival analysis: methods, models and applications","volume":"85","author":"Austin","year":"2017","journal-title":"Int. Stat. Rev."},{"key":"10.1016\/j.ijcard.2024.132866_bb0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.6000\/1929-6029.2015.04.03.7","article-title":"Multiple imputation by fully conditional specification for dealing with missing data in a large epidemiologic study","volume":"4","author":"Liu","year":"2015","journal-title":"Int. J. Stat. Med. Res."},{"key":"10.1016\/j.ijcard.2024.132866_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008389","article-title":"Association of race and ethnicity and anticoagulation in patients with atrial fibrillation dually enrolled in veterans health administration and Medicare: effects of Medicare Part D on prescribing disparities","volume":"15","author":"Essien","year":"2022","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2024.132866_bb0120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/clc.24077","article-title":"Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation","volume":"46","author":"Manning","year":"2023","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132866_bb0125","article-title":"Atrial fibrillation: comorbidities, lifestyle, and patient factors","volume":"37","author":"Shantsila","year":"2024","journal-title":"Lancet. Reg. Health. Eur."},{"key":"10.1016\/j.ijcard.2024.132866_bb0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40256-020-00457-3","article-title":"Non-adherence to thromboprophylaxis guidelines in atrial fibrillation: a narrative review of the extent of and factors in guideline non-adherence","volume":"21","author":"Gebreyohannes","year":"2021","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.ijcard.2024.132866_bb0135","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/europace\/euy039","article-title":"Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment","volume":"20","author":"Heidbuchel","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2024.132866_bb0140","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cjca.2023.01.020","article-title":"Barriers to guideline-directed anticoagulation in patients with atrial fibrillation: new approaches to an old problem","volume":"39","author":"Bhat","year":"2023","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132866_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002275","article-title":"Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry","volume":"10","author":"Apenteng","year":"2023","journal-title":"Open. Heart."},{"issue":"2021","key":"10.1016\/j.ijcard.2024.132866_bb0150","first-page":"373","volume":"42","author":"Hindricks","year":"2020","journal-title":"Euro. Heart. J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324014888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324014888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T11:17:08Z","timestamp":1738408628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324014888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"alternative-id":["S0167527324014888"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132866","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of care specialty with anticoagulant prescription and clinical outcomes in newly diagnosed atrial fibrillation: Results from the GARFIELD-AF registry","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"132866"}}